Previous 10 | Next 10 |
DALLAS and FORT WORTH, Texas, May 02, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally ...
The FDA has approved privately held NeuroSigma 's Monarch eTNS System for the first-line treatment of patients ages 7 - 12 years old with attention deficit hyperactivity disorder (ADHD), the first non-drug therapy for the condition available in the U.S. More news on: KemPharm, Inc., Sup...
Shares of Neos Therapeutics ( NEOS ) have trended higher in the last few weeks. This recovery begs the question of whether the company’s fundamental prospects have improved lately. I think the answer to that question is yes with a few caveats. One of the major caveats is that the impr...
Neos Therapeutics, Inc. (NEOS) Q4 2018 Results Conference Call March 14, 2019 09:30 AM ET Company Participants Richard Eisenstadt - CFO Jerry McLaughlin - CEO Conference Call Participants Louise Chen - Cantor Fitzgerald Jason Butler - JMP Securities Bill Maughan - Cowen a...
2018 was a strong year for pharmaceutical stocks, more specifically small-cap pharma stocks. Neos Therapeutics, Inc. (NASDAQ:NEOS), however, was not among that group and performed extremely poorly in 2018. Today, NEOS stock is making quite the comeback, up +20%. Will today...
Neos Therapeutics ( NEOS ) Q4 results : Revenues: $15.4M (+67.4%). More news on: Neos Therapeutics, Inc., Read more ...
Neos Therapeutics (NASDAQ: NEOS ): Q4 GAAP EPS of -$0.23 beats by $0.05 . More news on: Neos Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
- New commercial strategy including optimized salesforce structure, new distribution network and focus on improving net margins expected to accelerate path to profitability – - Company to host conference call today at 8:30am ET - DALLAS and FORT WORTH, Texas, March 1...
DALLAS and FORT WORTH, Texas, March 07, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orall...
DALLAS and FORT WORTH, Texas, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally...
News, Short Squeeze, Breakout and More Instantly...
Neos Therapeutics Inc. Company Name:
NEOS Stock Symbol:
NASDAQ Market:
Neos Therapeutics Inc. Website:
Penny Stock News Triggers Momentum In These Cheap Stocks When it comes to penny stocks, there are plenty of different catalysts to consider. You could look for general market trends or sector/industry-based themes. However, these are more along the line of technical catalysts. On the ot...
– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 18, 2021 at 10:00 a.m. Eastern Time – – Stockholders are encouraged to vote, no matt...
– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 18, 2021 at 10:00 a.m. Eastern Time – – Stockholders are encouraged to vote, no matt...